Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Robert Gish

Premium

Arrowhead Research has appointed Robert Gish as the chairman of its newly created hepatitis B clinical advisory board.

Gish is a professor of hepatology at the University of California, San Diego. As chairman of Arrowhead's advisory board, he will be responsible for assisting in the recruitment of other board members and will advise the company on clinical and regulatory issues, as well as the analysis of data related to its HBV drug candidate ARC-520.

The Scan

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.

Mitochondrial Replacement Therapy Embryos Appear Largely Normal in Single-Cell 'Omics Analyses

Embryos produced with spindle transfer-based mitochondrial replacement had delayed demethylation, but typical aneuploidy and transcriptome features in a PLOS Biology study.

Cancer Patients Report Quality of Life Benefits for Immune Checkpoint Inhibitors

Immune checkpoint inhibitor immunotherapy was linked in JAMA Network Open to enhanced quality of life compared to other treatment types in cancer patients.

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.